NO20015729L - Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme - Google Patents

Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme

Info

Publication number
NO20015729L
NO20015729L NO20015729A NO20015729A NO20015729L NO 20015729 L NO20015729 L NO 20015729L NO 20015729 A NO20015729 A NO 20015729A NO 20015729 A NO20015729 A NO 20015729A NO 20015729 L NO20015729 L NO 20015729L
Authority
NO
Norway
Prior art keywords
genes involved
diseases related
expression products
cholesterol metabolism
cholesterol
Prior art date
Application number
NO20015729A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015729D0 (no
Inventor
Patrice Denefle
Marie-Francoise Rosier-Montus
Isabelle Arnould-Reguigne
Catherine Prades
Christian Clepet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9906587A external-priority patent/FR2794131B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20015729D0 publication Critical patent/NO20015729D0/no
Publication of NO20015729L publication Critical patent/NO20015729L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO20015729A 1999-05-25 2001-11-23 Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme NO20015729L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9906587A FR2794131B1 (fr) 1999-05-25 1999-05-25 Produits d'expression de genes impliques dans des affections associees au metabolisme du cholesterol
US13945099P 1999-06-16 1999-06-16
PCT/FR2000/001426 WO2000071710A2 (fr) 1999-05-25 2000-05-25 Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol

Publications (2)

Publication Number Publication Date
NO20015729D0 NO20015729D0 (no) 2001-11-23
NO20015729L true NO20015729L (no) 2002-01-22

Family

ID=26234967

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015729A NO20015729L (no) 1999-05-25 2001-11-23 Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme

Country Status (11)

Country Link
EP (1) EP1183350A2 (fr)
JP (1) JP2003518918A (fr)
KR (1) KR20020033627A (fr)
AU (1) AU4931800A (fr)
BR (1) BR0010916A (fr)
CA (1) CA2371500A1 (fr)
HU (1) HUP0203164A2 (fr)
IL (1) IL145835A0 (fr)
MX (1) MXPA01011882A (fr)
NO (1) NO20015729L (fr)
WO (1) WO2000071710A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4726302B2 (ja) 1999-03-15 2011-07-20 ユニバーシティ オブ ブリティッシュ コロンビア Ａｂｃ１ポリペプチドおよびコレステロール水準を調節する方法と試薬
JP2004522410A (ja) * 2000-08-01 2004-07-29 アムジェン　インコーポレーテッド Ｃ３ｂ／Ｃ４ｂ補体レセプター様分子およびその使用
AT413701B (de) * 2001-11-06 2006-05-15 Bmt Medizinische Forschung Und Strukturelle und funktionelle charakterisierung von cdw92
JP5618172B2 (ja) 2007-01-05 2014-11-05 国立大学法人東京大学 抗ｐｒｇ−３抗体を用いる癌の診断および治療
CA2705509A1 (fr) 2007-11-14 2009-05-22 Forerunner Pharma Research Co., Ltd. Diagnostic et traitement du cancer a l'aide d'un anticorps anti-gpr49

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0941366A2 (fr) * 1996-11-06 1999-09-15 Whitehead Institute For Biomedical Research Marqueurs bialleliques

Also Published As

Publication number Publication date
JP2003518918A (ja) 2003-06-17
IL145835A0 (en) 2002-07-25
KR20020033627A (ko) 2002-05-07
CA2371500A1 (fr) 2000-11-30
WO2000071710A2 (fr) 2000-11-30
AU4931800A (en) 2000-12-12
MXPA01011882A (es) 2002-05-06
WO2000071710A3 (fr) 2001-05-17
NO20015729D0 (no) 2001-11-23
HUP0203164A2 (hu) 2002-12-28
EP1183350A2 (fr) 2002-03-06
BR0010916A (pt) 2002-02-19

Similar Documents

Publication Publication Date Title
NO20001244L (no) FremgangsmÕte ved avlevering av gener til antigenpresenterende celler i huden
ATE267144T1 (de) Kontinuierliche herstellung von auf kieselsäure- basierenden mikrogelen
WO2000045317A8 (fr) Procede permettant de simuler une reaction humaine a un stimulus
NO20030506D0 (no) Farmasöytiske sammensetninger av kolesterylesteroverföringsproteininhibitorer
AU2001285047A1 (en) Human genes and gene expression products
GB9928987D0 (en) Improvements in or relating to packaging/display of products
AU2003291689A8 (en) Stable liquid pharmaceutical formulation of antibodies that are prone to isomerization
EP0927270A4 (fr) Conservation de l'adn et de l'arn par lyophilisation de cellules humaines cultivees
NO20015729L (no) Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme
NO983775D0 (no) Regulering av gen-ekspresjon i eukaryoter
AU2001238511A1 (en) Cosmetics to support skin metabolism
IL146237A0 (en) Autotaxin variants and uses to treat diseases of metabolism
ZA200109129B (en) Expression products of genes involved in diseases related to cholesterol metabolism.
NO20011103D0 (no) Lokal avlevering av legemidler til hjertet
AU2003252979A1 (en) Improvements in or relating to the heating of products
NO20030052L (no) Gener og deres genprodukter relevante for mikrosatelitt ustabile (MSI+)tumorer
NO20014540L (no) Anvendelse av inulin i kjöttprodukter
AU2003226582A1 (en) Use of beta-aminoisobutyric acid for the treatment of diseases linked to the accumulation of triglycerides and cholesterol
NO20003108D0 (no) Anvendelse av melatoninenergiske ligander ved fremstilling av farmasøytiske sammensetninger
AU1520599A (en) Somatic transfer of modified genes to predict drug effects
NO20015731D0 (no) Anvendelse av PIT-emulsjoner i fermenteringsprosesser
DE69828876D1 (de) Zusammensetzung für die behandlung von erkrankungen, die mit apoptose einhergehen
AU2002243300A1 (en) Human genes and gene expression products isolated from human prostate
NO20015657L (no) Anvendelse av gener fra deoksy-D-xylulose- fosfatbiosyntesereaksjonsveien for endring av konsentrasjonen avisoprenoid
AU2001297804A1 (en) Compositions and methods relating to breast specific genes and proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application